Articles tagged with Molecular Chaperones
Researchers at Memorial Sloan Kettering Cancer Center found that the tail region of mRNAs helps fold thousands of critical regulatory proteins correctly. This discovery sheds new light on fundamental biology and has practical implications for laboratory research.
A new study from the Stowers Institute has identified a mechanism that makes fleeting moments unforgettable, revealing a critical step in forming long-lasting memories. The research discovered a specific type of chaperone protein that allows proteins to change shape and form functional amyloids that house long-term memory.
A new study found that proteins containing a widespread structural motif are more likely to misfold in E. coli. Essential proteins with the motif are more likely to be rescued by chaperones, suggesting an evolutionary mechanism to repair them.
The study reveals how heat shock chaperone proteins Hsp40 and Hsp70 bind each other and misfolded peptides, enabling the cellular machinery to work. The findings also identify a specific region of Hsp40 that handles protein handoffs, which could lead to therapeutic interventions for diseases.
A UC Riverside-led study found that adult stem cells rely on histone chaperones to maintain their regenerative capacity. The researchers discovered that disrupting these proteins can lead to specific changes in stem cell identity, potentially guiding them into desired cell types.
Researchers develop a method to remove copper from tumor cells, killing them. The nanofibers use copper-binding domains to grasp copper ions, disrupting cellular homeostasis and increasing oxidative stress.
A team from UNIGE and EPFL has demonstrated the Entropic Pulling mechanism of Hsp70 chaperones, a long-debated theory that explains their role in controlling protein quality. The study uses nanopore single-molecule technology to show that Hsp70s generate a strong force to manipulate protein structure, ruling out previous models.
Scientists at Sanford Burnham Prebys have developed a clearer picture of how crucial machinery in the human cell's recycling process for obsolete and misshapen proteins—known as proteasomes—are formed. The research team shed new light on how two protein chaperones bind on the top of the alpha subunit ring as it is constructed.
A team of scientists from Max Planck Institute found that extremely long-lived proteins in the ovary play a crucial role in preserving fertility. These proteins, known as chaperones, help maintain cellular processes and prevent misfolded proteins from aggregating.
Researchers discovered how altered protein folding enables the evolution of robust bodies in yeast, allowing them to become as strong and tough as wood. This finding highlights the power of non-genetic mechanisms in rapid evolutionary change and underscores the importance of mapping genetic information to understand adaptive behaviors.
Researchers develop technology that alleviates retinal pathologies by targeting mitochondrial chaperone TRAP1, which is implicated in the breakdown of blood-retinal barrier and pathological neovascularization. This treatment approach holds great promise for revolutionizing the treatment landscape for ischemic retinopathy.
A team of researchers at UMass Amherst has discovered a crucial role played by the enzyme UGGT in protein folding. The study reveals how UGGT 'tags' misfolded proteins with specific sugars, enabling chaperones to identify and correct errors.
A study by researchers from Osaka University found that HSP47, a collagen-specific molecular chaperone, is significantly expressed in fat tissue and correlates with body fat levels. High or low HSP47 expression was linked to high or low body fat levels in both humans and mice.
A new study reveals that the cellular chaperone protein GRP78 migrates to the nucleus under stress and alters gene activities, allowing cancer cells to become more mobile and invasive. This discovery offers potential new approaches for cancer treatment, including down-regulating GRP78 activity or preventing it from binding to ID2.
CHOP researchers have identified variants of a chaperone molecule that can enhance the loading of peptides across different HLA types, which could be used in cell therapy and immunization applications. The study found that chicken-derived TAPBPR proteins can react with multiple HLA allotypes and stabilize the empty MHC-I groove, boosti...
A new technological advancement at the University of Oklahoma will enable scientists to study whole macromolecular structures without deconstructing them. This breakthrough, supported by a $50,000 NIH grant, aims to analyze proteins as intact molecules, improving our understanding of their modifications and interactions.
Researchers at the University of Iowa have identified a fundamental biochemical mechanism underlying memory storage, which is impaired in Alzheimer's disease models. The study reveals that restoring this protein folding mechanism reverses memory impairment in mouse models.
A study led by New York University researchers found that the FDA-approved hepatitis C treatment telaprevir can increase bacterial sensitivity to antibiotics and reduce antibiotic resistance. The antiviral blocks the function of essential proteins in bacteria, revealing an opportunity to repurpose the drug to use alongside antibiotics.
Researchers at UMass Amherst discovered that molecular chaperones display 'selective promiscuity', enabling them to play a crucial role in maintaining healthy cells. This property allows chaperones to help many different proteins, which is essential for cell health.
Scientists at University of Basel have shown how chaperones stabilize immature bacterial membrane protein FhuA and guide it in the right folding direction, preventing misfolding. This discovery has significant implications for diseases caused by misfolded proteins like Alzheimer's and cystic fibrosis.
Researchers found that the quality of protective molecular chaperones declines dramatically with age, accelerating decline in those with neurodegenerative diseases. A subnetwork of 28 critical genes provides a basis for biomarkers and new therapeutics to prevent protein damage and cell dysfunction.
Researchers at the University of Massachusetts Amherst have deciphered key steps in the mechanism of Hsp70 molecular machines, which facilitate protein folding. The study provides insights into how chaperones work and their role in rapidly dividing cells, including cancer cells, highlighting potential therapeutic targets.
Researchers at UMass Amherst have identified two small molecule chaperones that can stabilize the defective alpha-NAGAL enzyme, offering hope for developing the first drug treatment for Schindler/Kanzaki disease. These molecules, DGJ and DGJNAc, can increase the amount of functional enzyme in cells.
Researchers have identified a mechanism by which small heat shock proteins collaborate with other molecular chaperones to disassemble amyloid fibers. This activity could lead to the development of therapeutic applications for neurodegenerative disorders, such as Parkinson's disease.
Researchers have identified DnaK as a central player in the chaperone network of E. coli, which helps proteins fold into their complex three-dimensional structures. This discovery sheds light on the mechanisms behind protein folding and has implications for understanding diseases such as Alzheimer's and Parkinson's.
Scientists have identified a protective mechanism that tries to collect and detoxify high levels of toxic amyloid beta peptide found in Alzheimer's disease. The molecular chaperone HspB1 works like a waste management company to protect brain cells from damage.
Scientists at Duke University Medical Center have identified compounds that activate a master regulator to increase the supply of protein chaperone molecules, which help fold proteins properly. This discovery provides a new approach to address protein misfolding, a common factor in degenerative nerve diseases.
Scientists believe that molecular chaperones, which help make and manage proteins, are crucial in both cancer and Alzheimer's. Disabling these molecules may lead to effective treatments for both diseases. Researchers are also exploring the potential of increasing their activity to halt disease progression.
Scientists have confirmed experiments that chemical chaperones can partially correct the genetic defect responsible for most cases of Gaucher's disease. This could lead to a cost reduction of at least 100-fold compared to current enzyme replacement therapy.
A study has identified a new molecular chaperone involved in assembling the enzyme complex I of mitochondria. The research found that B17.2L is a key protein required for this process and that it is mutated in patients with progressive encephalopathy.
Researchers found that elevated molecular chaperones promote longevity in C. elegans, a roundworm whose biochemical environment is similar to humans. This suggests that brief exposure to environmental and physiological stress can have long-term benefits to cells by unleashing molecular chaperones.
Researchers reveal the role of chaperone proteins in fiber assembly, leading to potential breakthroughs in treating urinary tract infections. The study provides insight into how disease-causing bacteria build and secrete proteins that enable them to cause disease.
A new class of drugs may prevent neurodegenerative disorders by fortifying neurons before disease onset. Geldanamycin, a natural antibiotic, boosts molecular chaperone activity, protecting against alpha-synuclein toxicity in Parkinson's disease.
A research team has visualized the interactions between molecular chaperones and protein aggregates, shedding light on how these protective proteins prevent disease. The study provides new insights into neurodegenerative diseases and could lead to the development of effective drugs.
A team of Penn researchers found that molecular chaperones can block the progression of neurodegenerative diseases like Parkinson's by preventing neuronal decay in Drosophila melanogaster. The study suggests that activating these molecules may be an effective approach to treating several human neurodegenerative diseases.
Researchers uncover crucial role of copper chaperone in delivering copper to superoxide dismutase enzyme, a key player in treating Lou Gehrig's disease. The study reveals the structure of the yeast copper chaperone protein, which helps protect copper from unwanted cellular interactions.
Researchers at Northwestern University have identified a new regulatory molecule, HSBP-1, that regulates the production of heat shock proteins in response to stress. This finding may lead to new insights into cell death associated with aging and diseases such as heart disease and stroke.
Researchers have discovered a chaperone protein from yeast that controls a new, protein-only form of inheritance called a yeast prion. The discovery links the mechanism responsible for this new form of inheritance to neurodegenerative diseases such as Alzheimer's and Creutzfeld-Jakob disease.
A team of scientists discovered a special protein that encases copper to transport it through the cell and deliver it to specific enzymes. The finding provides clues to toxic mechanisms of other metals and rare diseases related to copper metabolism.
A team of researchers at Northwestern University and the Mayo Clinic have identified two new proteins, Cyp-40 and p23, that act as molecular chaperones to fold proteins into an intermediate state. This discovery expands our understanding of what molecular chaperones are and their role in enhancing hormone sensitivity in cells.